Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.6K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.6K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

1.1K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.1K
Menopause01:28

Menopause

3.4K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.4K
The Menstrual Cycle01:19

The Menstrual Cycle

2.1K
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
2.1K
Oogenesis02:07

Oogenesis

67.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
67.6K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

6.0K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Keeps Faculty Coming Back? Factors Associated with Continued Pursuit of Faculty Development.

Medical science educator·2025
Same author

Nine lessons from the editor's chair.

Fertility and sterility·2025
Same author

Fostering Interprofessional Education and Practice: Organizational Outcomes of a Faculty Development Program for Educators Across Health Professions.

Cureus·2025
Same author

The obstetrics and gynecology resident experience in reproductive endocrinology and infertility: a survey of residency program directors.

F&S reports·2025
Same author

Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis.

Fertility and sterility·2025
Same author

The fetus need not be an antivaxxer.

Fertility and sterility·2023
Same journal

Obstetric Care for Patients With Cognitive Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

Clinical obstetrics and gynecology·2026
Same journal

Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

Clinical obstetrics and gynecology·2026
Same journal

Menstrual Management and Contraception for Patients With Disabilities.

Clinical obstetrics and gynecology·2026
Same journal

Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

Clinical obstetrics and gynecology·2026
See all related articles

Related Experiment Video

Updated: Nov 20, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.4K

Menstrual Dysfunction in PCOS.

Karrie Walker1, Alan H Decherney, Rhiana Saunders

  • 1National Institutes of Health, Bethesda, Maryland.

Clinical Obstetrics and Gynecology
|January 22, 2021
PubMed
Summary
This summary is machine-generated.

Polycystic ovary syndrome (PCOS) often causes menstrual irregularities. Lifestyle changes, hormonal contraception, or metformin are effective treatments for managing PCOS symptoms and reducing health risks.

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.6K

Related Experiment Videos

Last Updated: Nov 20, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.4K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.6K

Area of Science:

  • Reproductive endocrinology
  • Gynecology

Background:

  • Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by menstrual irregularities, often due to anovulation or oligoovulation.
  • These irregularities significantly impact women's health and quality of life.

Purpose of the Study:

  • To outline evidence-based, first-line management strategies for menstrual irregularities in women with PCOS.
  • To provide guidance on treatment selection based on patient characteristics and reproductive goals.

Main Methods:

  • Review of current clinical guidelines and relevant scientific literature.
  • Analysis of treatment efficacy for menstrual cycle regulation and associated health benefits.

Main Results:

  • Dietary and lifestyle modifications are recommended as first-line interventions for overweight or obese women with PCOS.
  • For women not seeking fertility, combination low-dose hormonal contraception is the most effective first-line choice for regulating cycles.
  • Hormonal contraception (combined or progestin-only) offers added benefits of reducing endometrial hyperplasia and cancer risks.
  • Metformin is a suitable medical option for improving ovulation rates in women who cannot use hormonal contraception or are trying to conceive.

Conclusions:

  • Effective management of PCOS-related menstrual irregularities involves tailored interventions.
  • Hormonal contraception and metformin represent key therapeutic options for cycle regulation and risk reduction in PCOS.